logo

For the Inventor, By the Inventor

East Hanover, NJ, United States of America

Richard E Brown

This inventor holds 45 USPTO granted patents and 1 published patent application, primarily in Anti-Allergy Compounds. Top assignees: Warner-Lambert Company, Usv Pharmaceutical Corporation, Xerox Corporation. Active years: 1976-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard E Brown. Retrieved from https://idiyas.com/inventor/richard-e-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 180(Granted Patents)


Location History:

  • Del Mar, CA (US) (1977)
  • Hanover, NJ (US) (1976 - 1981)
  • East Hanover, NJ (US) (1976 - 1987)

Company Filing History:

goldMedal29 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal12 out of 128 
 
Usv Pharmaceutical Corporation
 patents
bronzeMedal1 out of 24,261 
 
Xerox Corporation
 patents
4. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-1987

Loading Chart...
Areas of Expertise:
Thiazoloquinoline
Triazoloquinoxaline
Imidazoquinoline
Oxazoloquinoline
Pyridotriazolopyrazine
Indolopyrones
CNS Depressants
Bronchodilators
Benzoxazinediones
Substituted Benzopyrano
Anti-Allergic Activity
Asthma Treatment
45 patents (USPTO):Explore Patents
1. 4698346 - Thiazolo[5,4-h]quinoline compounds useful as anti-allergy agents (1987-10-06),
2. 4668678 - Triazoloquinoxalin-1,4-diones (1987-05-26),
3. 4656281 - Imidazo quinoline compounds useful as anti-allergy agents (1987-04-07),
4. 4563463 - 2-Oxo-1,3-oxazolo[4,5-h] quinolines useful as anti-allergy agents (1986-01-07),
5. 4522947 - Certain 1,3-oxazolo[4,5H]quinolines useful as anti-allergy agents (1985-06-11),
6. 4507300 - Pyridotriazolopyrazine-diones for treating allergy (1985-03-26),
7. 4490373 - Method of treating asthma (1984-12-25),
8. 4440929 - Imidazoquinoxaline compounds (1984-04-03),
9. 4405633 - Method of treatment of asthma (1983-09-20),
10. 4400382 - Thiazoloquinoxalin-1,4-diones for treating allergy (1983-08-23),
11. 4316904 - Indolopyrone tetrazoles and carboxamidotetrazoles having antiallergic (1982-02-23),
12. 4307091 - Process for treatment of allergic conditions with benzoxazinediones (1981-12-22),
13. 4298742 - Esters of benzoxa(thia)zole-2-carboxylic acids (1981-11-03),
14. 4276296 - Substituted benzopyrano[3,4-c]pyridines, compositions and use thereof (1981-06-30),
15. 4188326 - Indolopyrones having anti-allergic activity (1980-02-12),

Title: Richard E. Brown: A Pioneer in Anti-Allergic Compound Innovations

Introduction

Richard E. Brown, based in East Hanover, NJ, has made significant contributions to the field of pharmaceuticals, with an impressive record of 44 patents. His work primarily focuses on developing innovative compounds, particularly in the realm of anti-allergenic agents.

Latest Patents

Among his latest patents are innovative thiazolo[5,4-h]quinoline compounds that serve as potential anti-allergy agents. These compounds are characterized by a specific formula that includes a variety of substitutions possible for R₁ and R₂, such as lower alkyl or halo groups. Another noteworthy development is the triazoloquinoxalin-1,4-diones, which are also explored for their anti-allergic properties.

Career Highlights

Richard has a remarkable career that includes pivotal roles at Warner-Lambert Company and USV Pharmaceutical Corporation. His work at these renowned companies has been crucial in advancing the understanding and application of pharmaceutical compounds.

Collaborations

During his career, Richard E. Brown collaborated with notable professionals, including John Shavel, Jr. and Chester Puchalski. These collaborations have helped enhance the innovative landscape of pharmaceutical research and development.

Conclusion

Richard E. Brown stands out as a significant figure in the innovation of anti-allergic compounds. His extensive patent portfolio demonstrates his dedication to advancing pharmaceutical science, contributing to better health solutions for allergy sufferers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…